How Will the Market React to Olema Pharmaceuticals Inc (OLMA) Stock Getting a Bullish Rating

Olema Pharmaceuticals Inc (OLMA) stock has gained 17.94% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Olema Pharmaceuticals Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on OLMA!

See Full OLMA Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor. InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon. The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With OLMA Stock Today?

Olema Pharmaceuticals Inc (OLMA) stock is lower by -0.74% while the S&P 500 is higher by 0.8% as of 1:19 PM on Wednesday, Feb 7. OLMA is down -$0.11 from the previous closing price of $15.50 on volume of 202,028 shares. Over the past year the S&P 500 has gained 21.47% while OLMA is higher by 239.51%. OLMA lost -$2.32 per share in the over the last 12 months. To screen for more stocks like Olema Pharmaceuticals Inc click here.

More About Olema Pharmaceuticals Inc

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. Click Here to get the full Stock Report for Olema Pharmaceuticals Inc stock.